Keywords: novartis, 1st, qtr, pharma, sales, rise, switzerland
Novartis 1st qtr pharma sales rise 13%
Article | 19 April 2001
Switzerland's Novartis posted pharmaceutical sales of 4.5 billion ($2.64billion) Swiss francs, a rise of 13% in local currency terms (or 10% in Swiss ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
